The prediction of COOH functionalized carbon nanotube application in melphalan drug delivery
https://doi.org/10.17586/2220-8054-2019-10-4-438-446
Abstract
Using quantum chemical calculations, noncovalent functionalization of melphalan drug on the surface of functionalized carbon nanotube (NT) have been examined. Quantum molecular descriptors of noncovalent interactions were investigated. It was concluded that binding of drug melphalan into COOH-functionalized NT (FNT) is exothermic and makes the system stable. Comparison between FNT and COCl functionalized NT (F0NT) showed that FNT has more binding energy and may act as a carrier for drug delivery (if the noncovalent functionalization is desired). The OH and NH2 groups of melphalan may bond to Cl (COCl mechanism) and COOH (COOH mechanism) of F0NT and FNT, respectively. Therefore, four mechanisms for the covalent functionalization have been investigated. The transition states of four pathways were optimized and activation parameters were evaluated. The high barriers of COOH pathway are greater than those of COCl pathway and therefore F0NT is suitable carrier for covalent functionalization.
About the Authors
Hadi Lari
Department of Chemistry, Mashhad Branch, Islamic Azad University
Islamic Republic of Iran
Islamic Republic of Iran
Mashhad
Ali Morsali
Department of Chemistry, Mashhad Branch, Islamic Azad University
Islamic Republic of Iran
Islamic Republic of Iran
Mashhad
Mohammad Momen Heravi
Department of Chemistry, Mashhad Branch, Islamic Azad University
Islamic Republic of Iran
Islamic Republic of Iran
Mashhad
References
1. Pennock G.D., Dalton W.S., et al. Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J. Natl. Cancer Inst., 1991, 83 (2), P. 105–110.
2. Lindley C., McCune J.S., et al. Perception of chemotherapy side effects cancer versus noncancer patients. Cancer pract., 1999, 7 (2), P. 59–65.
3. Hughes G.A. Nanostructure-mediated drug delivery. Nanomedicine in Cancer, Pan Stanford, 2017, P. 47–72.
4. Mitra S., Sasmal H.S., et al. Targeted drug delivery in covalent organic nanosheets (CONs) via sequential postsynthetic modification. J. Am. Chem. Soc., 2017, 139 (12), P. 4513–4520.
5. Ramasamy T., Ruttala H.B., et al. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review. J. Controlled Release, 2017, 258, P. 226–253.
6. Liu Q., Das M., Liu Y., Huang L. Targeted drug delivery to melanoma. Adv. Drug Deliv. Rev., 2018, 127, P. 208–221.
7. Chauhan A.S. Dendrimers for Drug Delivery. Molecules, 2018, 23 (4), 938.
8. Marasini N., Haque S., Kaminskas L.M. Polymer-drug conjugates as inhalable drug delivery systems: A review. Curr. Opin. Colloid Interface Sci., 2017, 31, P. 18–29.
9. Pattni B.S., Chupin V.V., Torchilin V.P. New developments in liposomal drug delivery. Chem. Rev., 2015, 115 (19), P. 10938–10966.
10. Ghosh P., Han G., et al. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev., 2008, 60 (11), P. 1307–1315.
11. Arami H., Khandhar A., Liggitt D., Krishnan K.M. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem. Soc. Rev., 2015, 44 (23), P. 8576–8607.
12. Etebari N., Morsali A., Beyramabadi S.A. Structural and Mechanistic Studies of γ-Fe2O3 Nanoparticle as Capecitabine Drug Nanocarrier. Chinese J. Struc. Chem., 2018, 3, P. 375–382.
13. Naghavi F., Morsali A., Bozorgmehr M.R. Molecular mechanism study of surface functionalization of silica nanoparticle as an anticancer drug nanocarrier in aqueous solution. J. Mol. Liq., 2019, 282, P. 392–400.
14. Spencer D.S., Puranik A.S., Peppas N.A. Intelligent nanoparticles for advanced drug delivery in cancer treatment. Current opinion in chemical engineering, 2015, 7, P. 84–92.
15. Bokarev A., Plastun I. Possibility of drug delivery due to hydrogen bonds formation in nanodiamonds and doxorubicin: molecular modeling. Nanosystems: Phys. Chem. Math., 2018, 9 (3), P. 370–377.
16. Khorram R., Morsali A., et al. Mechanistic, Energetic and Structural Aspects of the Adsorption of Carmustine on the Functionalized Carbon Nanotubes. Chinese J. Struc. Chem., 2017, 10, 007.
17. John A.A., Subramanian A.P., et al. Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery. Int. J. Nanomedicine, 2015, 10, 4267.
18. Kamel M., Raissi H., Morsali A., Shahabi M. Assessment of the adsorption mechanism of Flutamide anticancer drug on the functionalized single-walled carbon nanotube surface as a drug delivery vehicle: An alternative theoretical approach based on DFT and MD. Appl. Surf. Sci., 2018, 434, P. 492–503.
19. d’Amora M., Giordani S. Carbon Nanomaterials for Nanomedicine. Smart Nanoparticles for Biomedicine, Elsevier, 2018, P. 103–113.
20. Mikheev I., Pirogova M., et al. Optimization of the solventexchange process for highyield synthesis of aqueous fullerene dispersions. Nanosystems: Phys. Chem. Math., 2018, 9 (1), P. 41–45.
21. Shaki H., Morsali A., et al. Mechanistic, energetic and structural studies of single-walled carbon nanotubes functionalized with penicillamine. J. Serb. Chem. Soc., 2018, 83 (2), P. 167–179.
22. Barnett C.J., Gowenlock C.E., et al. Spatial and contamination-dependent electrical properties of carbon nanotubes. Nano Lett., 2018, 18 (2), P. 695–700.
23. Kholmanov I.N., Magnuson C.W., et al. Optical, electrical, and electromechanical properties of hybrid graphene/carbon nanotube films. Adv. Mater., 2015, 27 (19), P. 3053–3059.
24. Il’ina M., Il’in O., et al. The memristive behavior of nonuniform strained carbon nanotubes. Nanosystems: Phys. Chem. Math., 2018, 9 (1), P. 76–78.
25. Abdalla S., Al-Marzouki F., Al-Ghamdi A.A., Abdel-Daiem A. Different technical applications of carbon nanotubes. Nanoscale Res. Lett., 2015, 10 (1), 358.
26. Sozykin S., Beskachko V. Optical properties of defective carbon nanotube (7,7). Nanosystems: Phys. Chem. Math., 2018, 9 (1), P. 73–75.
27. Cheng H.-M., Liu C., Hou P.-X. Field emission from carbon nanotubes. Nanomaterials Handbook, Second Edition, CRC Press, 2017, P. 255– 272.
28. Ferreira F., Franceschi W., et al. Dodecylamine functionalization of carbon nanotubes to improve dispersion, thermal and mechanical properties of polyethylene based nanocomposites. Appl. Surf. Sci., 2017, 410, P. 267–277.
29. Bocharov G., Egin M., Eletskii A., Kuznetsov V. Filling carbon nanotubes with argon. Nanosystems: Phys. Chem. Math., 2018, 9 (1), P. 85–88.
30. Chandrasekhar P. CNT Applications in Drug and Biomolecule Delivery. Conducting Polymers, Fundamentals and Applications, Springer, 2018, P. 61–64.
31. Meher J.G., Kesharwani P., et al. Carbon Nanotubes (CNTs): A Novel Drug Delivery Tool in Brain Tumor Treatment. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, Elsevier, 2018, P. 375–396.
32. Pham-Huy C., Dramou P., et al. Carbon Nanotubes Used as Nanocarriers in Drug and Biomolecule Delivery. Drug Delivery Approaches and Nanosystems, 1, Apple Academic Press, 2017, P. 163–212.
33. Sciortino N., Fedeli S., et al. Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time. Int. J. Pharm., 2017, 521 (1–2), P. 69–72.
34. Karimi M., Solati N., et al. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin. Drug Deliv., 2015, 12 (7), P. 1089–1105.
35. Zhang H., Hou L., et al. In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted single-walled carbon nanotubes system. Curr. Pharm. Biotechnol., 2014, 14 (13), P. 1105–1117.
36. Unnati S., Shah R. Review: Nano carrier systems for cancer therapy. Int. J. Pharm. Technol., 2011, 3 (2), P. 927–946.
37. Mehra N.K., Palakurthi S. Interactions between carbon nanotubes and bioactives: a drug delivery perspective. Drug Discov. Today, 2016, 21 (4), P. 585–597.
38. Mehra N.K., Jain K., Jain N.K. Pharmaceutical and biomedical applications of surface engineered carbon nanotubes. Drug Discov. Today, 2015, 20 (6), P. 750–759.
39. Hampel S., Vittorio O., Cirillo G., Makharza S. Physiological and Clinical Considerations of Drug Delivery Systems Containing Carbon Nanotubes and Graphene. Drug Delivery Approaches and Nanosystems, 2, Apple Academic Press, 2017, P. 229–248.
40. You Y., Wang N., et al. Designing dual-functionalized carbon nanotubes with high blood-brain-barrier permeability for precise orthotopic glioma therapy. Dalton Trans., 2019, 48, P. 1569–1573.
41. Samal S.K. Cancer and Carbon Nano Tubes: A Promising Hope of Future. Scientific Review, 2018, 4 (7), P. 64–67.
42. Menard-Moyon C. Applications of Carbon Nanotubes in the Biomedical Field.´ Smart Nanoparticles for Biomedicine, Elsevier, 2018, P. 83– 101.
43. Feazell R.P., Nakayama-Ratchford N., Dai H., Lippard S.J. Soluble single-walled carbon nanotubes as longboat delivery systems for platinum (IV) anticancer drug design. J. Am. Chem. Soc., 2007, 129 (27), P. 8438–8439.
44. Karimi-Maleh H., Tahernejad-Javazmi F., et al. A novel DNA biosensor based on a pencil graphite electrode modified with polypyrrole/functionalized multiwalled carbon nanotubes for determination of 6-mercaptopurine anticancer drug. Industrial & Engineering Chemistry Research, 2015, 54 (14), P. 3634–3639.
45. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water- Soluble carbon nanotubes for drug loading and delivery. ACS Nano, 2007, 1 (1), P. 50–56.
46. Wolski P., Nieszporek K., Panczyk T. Pegylated and folic acid functionalized carbon nanotubes as pH controlled carriers of doxorubicin. Molecular dynamics analysis of the stability and drug release mechanism. PCCP, 2017, 19 (13), P. 9300–9312.
47. Lay C.L., Liu H.Q., Tan H.R., Liu Y. Delivery of paclitaxel by physically loading onto poly (ethylene glycol)(PEG)-graftcarbon nanotubes for potent cancer therapeutics. Nanotechnology, 2010, 21 (6), 065101.
48. Samor`ı C., Ali-Boucetta H., et al. Enhanced anticancer activity of multi-walled carbon nanotubemethotrexate conjugates using cleavable linkers. Chem. Commun., 2010, 46 (9), P. 1494–1496.
49. Razzazan A., Atyabi F., Kazemi B., Dinarvand R. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. Mater. Sci. Eng.: C, 2016, 62, P. 614–625.
50. Chae S., Kim D., et al. Encapsulation and Enhanced Delivery of Topoisomerase I Inhibitors in Functionalized Carbon Nanotubes. ACS Omega, 2018, 3 (6), P. 5938–5945.
51. Yi W., Zhang P., et al. Enhanced response of tamoxifen toward the cancer cells using a combination of chemotherapy and photothermal ablation induced by lentinan-functionalized multi-walled carbon nanotubes. Int. J. Biol. Macromol., 2018, 120, P. 1525–1532.
52. Wang C., Li W. Preparation, characterization, and in vitro and vivo antitumor activity of oridonin-conjugated multiwalled carbon nanotubes functionalized with carboxylic group. Journal of Nanomaterials, 2016, 2016, 3439419.
53. Karadas-Bakirhan N., Patris S., et al. Determination of the anticancer drug sorafenib in serum by adsorptive stripping differential pulse voltammetry using a chitosan/multiwall carbon nanotube modified glassy carbon electrode. Electroanalysis, 2016, 28 (2), P. 358–365.
54. Haroun A., Amin H., El-Alim S.A. Immobilization and In vitro Evaluation of Soyasapogenol B onto Functionalized Multi-Walled Carbon Nanotubes. IRBM, 2018, 39 (1), P. 35–42.
55. Facon T., Mary J.Y., et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 9906): a randomised trial. The Lancet, 2007, 370 (9594), P. 1209– 1218.
56. Horowitz M.E., Etcubanas E., et al. Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development. J. Clin. Oncol., 1988, 6 (2), P. 308–314.
57. Lotfi M., Morsali A., Bozorgmehr M.R. Comprehensive quantum chemical insight into the mechanistic understanding of the surface functionalization of carbon nanotube as a nanocarrier with cladribine anticancer drug. Appl. Surf. Sci., 2018, 462 (34), P. 720–729.
58. Saikia N., Deka R.C. Adsorption of isoniazid and pyrazinamide drug molecules onto nitrogen-doped single-wall carbon nanotubes: an ab initio study. Struct. Chem., 2014, 25 (2), P. 593–605.
59. Chegini H., Morsali A., Bozorgmehr M., Beyramabadi S. Theoretical study on the mechanism of covalent bonding of dapsone onto functionalised carbon nanotubes: effects of coupling agent. Prog. React. Kinet. Mech., 2016, 41 (4), P. 345–355.
60. Xu H., Li L., Fan G., Chu X. DFT study of nanotubes as the drug delivery vehicles of Efavirenz. Comput. Theor. Chem., 2018, 1131, P. 57–68.
61. Kamel M., Raissi H., Morsali A. Theoretical study of solvent and co-solvent effects on the interaction of Flutamide anticancer drug with Carbon nanotube as a drug delivery system. J. Mol. Liq., 2017, 248, P. 490–500.
62. Shahabi D., Tavakol H. DFT, NBO and molecular docking studies of the adsorption of fluoxetine into and on the surface of simple and sulfur-doped carbon nanotubes. Appl. Surf. Sci., 2017, 420, P. 267–275.
63. Naderi S., Morsali A., Bozorgmehr M.R., Beyramabadi S.A. Mechanistic, energetic and structural studies of carbon nanotubes functionalised with dihydroartemisinin drug in gas and solution phases. Phys. Chem. Liq., 2018, 56 (5), P. 610–618.
64. Ketabi S., Rahmani L. Carbon nanotube as a carrier in drug delivery system for carnosine dipeptide: A computer simulation study. Mater. Sci. Eng.: C, 2017, 73, P. 173–181.
65. Wong B.S., Yoong S.L., et al. Carbon nanotubes for delivery of small molecule drugs. Adv. Drug Deliv. Rev., 2013, 65 (15), P. 1964–2015.
66. Frisch M., Trucks G., et al. Gaussian 09, Revision B. 01 [computer software]. Wallingford, CT, USA: Gaussian. Inc. Google Scholar, 2010.
67. Tomasi J., Persico M. Molecular interactions in solution: an overview of methods based on continuous distributions of the solvent. Chem. Rev., 1994, 94 (7), P. 2027–2094.
68. Coitino E.L., Tomasi J., Cammi R. On the evaluation of the solvent polarization apparent charges in the polarizable continuum model: a new formulation. J. Comput. Chem., 1995, 16 (1), P. 20–30.
69. Parr R.G., Szentpaly L.v., Liu S. Electrophilicity index. J. Am. Chem. Soc., 1999, 121 (9), P. 1922–1924.
70. Lin T., Bajpai V., Ji T., Dai L. Chemistry of carbon nanotubes. Aust. J. Chem., 2003, 56 (7), P. 635–651.
Review
For citations:
Lari H., Morsali A., Heravi M. The prediction of COOH functionalized carbon nanotube application in melphalan drug delivery. Nanosystems: Physics, Chemistry, Mathematics. 2019;10(4):438–446. https://doi.org/10.17586/2220-8054-2019-10-4-438-446
Views:
25
Email this article 